About Source Molecular
Source Molecular is a company based in Miami (United States) founded in 2002 was acquired by LuminUltra in November 2020.. Source Molecular has raised $1.62 million across 1 funding round from investors including LuminUltra and New World Angels. Source Molecular offers products and services including SMART qPCR Management Platform, SMART qPCR Reagents and Kits, and COVID-19 Testing Services. Source Molecular operates in a competitive market with competitors including AFYREN, Spore Biotechnologies, GBA Group, Biopsin and Mesosil, among others.
- Headquarter Miami, United States
-
Sectors
HealthcareEnvironment
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Source Molecular Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.62 M (USD)
in 1 rounds
-
Latest Funding Round
$1.62 M (USD), Series A
Jul 11, 2017
-
Investors
LuminUltra
& 1 more
-
Employee Count
Employee Count
-
Acquired by
LuminUltra
(Nov 30, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Source Molecular
Source Molecular offers a comprehensive portfolio of products and services, including SMART qPCR Management Platform, SMART qPCR Reagents and Kits, and COVID-19 Testing Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for managing environmental qPCR tests.
Reagents for pathogen and DNA marker analysis.
Environmental testing for SARS-CoV-2 detection.
Funding Insights of Source Molecular
Source Molecular has successfully raised a total of $1.62M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.62 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $1.6M
-
First Round
First Round
(11 Jul 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Series A - Source Molecular | Valuation | New World Angels |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Source Molecular
Source Molecular has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include LuminUltra and New World Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage funding and guidance are provided to Florida entrepreneurs.
|
Founded Year | Domain | Location | |
|
Microbial concentrations in water are monitored via ATP luminometer technology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Source Molecular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Source Molecular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Source Molecular Comparisons
Competitors of Source Molecular
Source Molecular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AFYREN, Spore Biotechnologies, GBA Group, Biopsin and Mesosil, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| domain | founded_year | HQ Location |
Microbial detection technology is developed for life science industries.
|
|
| domain | founded_year | HQ Location |
GBA Group is recognized as a leading life sciences service provider.
|
|
| domain | founded_year | HQ Location |
Real-time microbial detection system is developed for product testing.
|
|
| domain | founded_year | HQ Location |
Antimicrobial materials are developed for infection prevention in medical devices.
|
|
| domain | founded_year | HQ Location |
Provider of analytical and quality testing services for drug development and diagnostics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Source Molecular
Frequently Asked Questions about Source Molecular
When was Source Molecular founded?
Source Molecular was founded in 2002 and raised its 1st funding round 15 years after it was founded.
Where is Source Molecular located?
Source Molecular is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Is Source Molecular a funded company?
Source Molecular is a funded company, having raised a total of $1.62M across 1 funding round to date. The company's 1st funding round was a Series A of $1.62M, raised on Jul 11, 2017.
What does Source Molecular do?
Source Molecular was founded in 2002 and is headquartered in Miami, United States. Technology focused on microbial source tracking is developed and supplied by the company, primarily within the biotechnology sector. Operations center on delivering tools for identifying and monitoring microbial origins in environmental samples. Services are extended to clients in water quality and public health fields, with the domain sourcemolecular.com used for online access.
Who are the top competitors of Source Molecular?
Source Molecular's top competitors include AFYREN, Spore Biotechnologies and NCIMB.
What products or services does Source Molecular offer?
Source Molecular offers SMART qPCR Management Platform, SMART qPCR Reagents and Kits, and COVID-19 Testing Services.
Who are Source Molecular's investors?
Source Molecular has 2 investors. Key investors include LuminUltra, and New World Angels.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.